.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The UK-ROX randomised clinical trial tested whether routinely reducing oxygen exposure would improve outcomes in mechanically ventilated adults in the ICU. More than 16,000 patients were enrolled, with the conservative strategy targeting an oxygen saturation of about 90% and usual care left to treating clinicians. The trial successfully reduced exposure to supplemental oxygen in the conservative group, demonstrating that a lower-oxygen strategy could be implemented at scale. However, mortality at 90 days was not significantly different between the two groups. There were also no significant differences in ICU or hospital length of stay or days alive and free from organ support. The study is especially relevant because oxygen can be both life-saving and harmful. Earlier trials raised concerns about hyperoxia, but the UK-ROX results suggest that simply lowering oxygen exposure across all mechanically ventilated patients does not automatically translate into better survival. For HCPs, the practical approach is to avoid unnecessary hyperoxia while also avoiding dogmatic low targets. Oxygen should be titrated to a clinically appropriate target, with ongoing reassessment as the patient's disease and ventilation change. The finding fits CritiCARE's focus on oxygen therapy and the broader move toward physiology-guided, individualised ICU management.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The UK-ROX randomised clinical trial tested whether routinely reducing oxygen exposure would improve outcomes in mechanically ventilated adults in the ICU. More than 16,000 patients were enrolled, with the conservative strategy targeting an oxygen saturation of about 90% and usual care left to treating clinicians. The trial successfully reduced exposure to supplemental oxygen in the conservative group, demonstrating that a lower-oxygen strategy could be implemented at scale. However, mortality at 90 days was not significantly different between the two groups. There were also no significant differences in ICU or hospital length of stay or days alive and free from organ support. The study is especially relevant because oxygen can be both life-saving and harmful. Earlier trials raised concerns about hyperoxia, but the UK-ROX results suggest that simply lowering oxygen exposure across all mechanically ventilated patients does not automatically translate into better survival. For HCPs, the practical approach is to avoid unnecessary hyperoxia while also avoiding dogmatic low targets. Oxygen should be titrated to a clinically appropriate target, with ongoing reassessment as the patient's disease and ventilation change. The finding fits CritiCARE's focus on oxygen therapy and the broader move toward physiology-guided, individualised ICU management.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
2 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
